Carlecortemcel-L

DB17186InvestigationalCell transplant therapies

Carlecortemcel-L: Overview.

Also known as
Allogeneic ex vivo expanded umbilical cord blood cells

What you can answer from here — as of April 23, 2025

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Carlecortemcel-L, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In